替瑞帕肽减重计算器
SURMOUNT-1：5mg≈15%，10mg≈19.5%，15mg≈20-22.5%
替瑞帕肽（Mounjaro®/Zepbound®）在SURMOUNT-1中显示了批准GLP-1/GIP激动剂中最高的记录减重率。输入起始体重和维持剂量获取估算。
按维持剂量的减重（SURMOUNT-1）
Tirzepatide produces some of the largest average weight loss of any approved medication, and the higher your maintenance dose, the more you tend to lose. Most of the loss comes over the first 9–18 months as you titrate up and your body responds.
In SURMOUNT-1 (72 weeks), the 5 mg dose averaged about 15%, 10 mg about 19.5%, and 15 mg about 20–22.5%. To estimate your pounds lost, multiply your starting weight by the percentage for your dose.
替瑞帕肽随时间的典型减重
| 治疗时间 | 典型总减重 |
|---|---|
| 5 mg | ~15%Best |
| 10 mg | ~19.5% |
| 15 mg | ~20–22.5% |
按起始体重估算减重
| 起始体重 | 减重15%时 | 减重20%时 |
|---|---|---|
| Month 1 | ~3–4% | |
| Month 3 | ~7–9% | |
| Month 6 | ~12–15% | |
| Month 12 | ~18–21% | |
| 72 weeks | up to ~22.5% |
Estimated pounds lost by starting weight
| Starting weight | At 15% (≈5 mg) | At 20% (≈10–15 mg) |
|---|---|---|
| 150 lb | 23 lb → 127 lb | 30 lb → 120 lbBest |
| 180 lb | 27 lb → 153 lb | 36 lb → 144 lb |
| 200 lb | 30 lb → 170 lb | 40 lb → 160 lb |
| 250 lb | 38 lb → 212 lb | 50 lb → 200 lb |
| 300 lb | 45 lb → 255 lb | 60 lb → 240 lb |
What changes your result — and safety
Your maintenance dose is the biggest lever, followed by how long you stay on treatment, diet quality and protein, activity and resistance training, sleep, and individual biology. Reaching and holding 10–15 mg, paired with lifestyle changes, tends to land at the upper end.
These are estimates from trial averages, not medical advice or a guarantee. Your prescriber sets your dose and plan. Track your actual weekly weight in Shotlee to see your real curve instead of an average.
常见问题
SURMOUNT-1：5mg→约15%，10mg→约19.5%，15mg→约20.9%，72周内。
在SURMOUNT-5中，替瑞帕肽15mg比司美格鲁肽2.4mg多减约47%。
4-8周内出现效果；完全滴定约20周。
10mg约减19.5%——非常接近15mg。
可以——免费。
在Shotlee中追踪替瑞帕肽进展
体重、剂量和注射 — 免费。